Abstract
IL-18 is produced during the acute immune response by macrophages and immature dendritic cells. IL-18 receptors are induced on T cells and NK cells by IL-12 and together they enhance a cellular immune response. We constructed retroviral and adenoviral vectors encoding the mature bioactive murine IL-18 in order to examine their immune and antitumor effects in murine tumor models. Secretion of bioactive IL-18 from murine tumor cells was facilitated by transfecting them with recombinant viral vectors carrying the prepro leader sequence of human parathyroid hormone fused to the 5′ end of the mature murine IL-18 cDNA. Direct injection of the IL-18 recombinant adenoviral vector (Ad.PTH.IL-18) into an established MCA205 murine fibrosarcoma completely eradicated tumor in all animals with concomitant induction of protective systemic immunity. Co-administration of systemic IL-12 provided synergistic antitumor effects when combined with peritumoral injections of Ad.PTH.IL-18 without apparent side-effects as we observed with systemic administration of IL-18. Depletion of asialo GM-1+ cells completely abrogated the antitumor effects of Ad.PTH.IL-18, suggesting a major role for NK cells in mediating the anti-tumor effects of IL-18. Peritumoral injection of Ad.PTH.IL-18 was also associated with reduced numbers of CD8+ cells found within the tumor (HBSS versus Ad.PTH.IL-18, P < 0.0001). this suggests that il-18 could be utilized as an alternative cancer gene therapy especially when combined with systemic administration of il-12.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Antonysamy M et al. Interleukin 16, 17, 18. In: Thomson AW (ed) . The Cytokine Handbook, Third edition Academic Press:London 1998 465–469
Maeure MJ, Lotze MT . Tumor recognition by the cellular immune system: new aspects of tumor immunology Int Rev Immunol 1997 14: 97–132
Lotze MT et al. Interleukin-2 (IL-2) and the role of dendritic cells (DCs) for cancer therapy Cancer J Sci Am 1997 3: S109–S114
Lotze MT . Future directions for rIL-2 in cancer: a chronic inflammatory disorder Cancer J Sci Am 1997 3: S106–S109
Okamura H et al. A novel cytokine that induces IFN-γ production Nature 1995 378: 88–91
Ahn HJ et al. A mechanism underlying synergy between IL-12 and IFN-γ-inducing factor in enhanced production of IFN-γ J Immunol 1997 159: 2125–2131
Robinson D et al. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-γ production and activates IRAK and NFκB Immunity 1997 7: 571–581
Micallef MJ et al. In vivo antitumor effects of murine interferon-γ-inducing factor/interleukin-18 in mice bearing syngeneic Meth A sarcoma malignant ascites Cancer Immunol Immunother 1997 43: 361–367
Osaki T et al. IFN-γ-inducing factor/IL-18 administration mediates IFN-γ and IL-12 independent anti-tumor effects J Immunol 1998 160: 1742–1749
Ghayur T et al. Caspase-1 processes IFN-γ-inducing factor and regulates LPS-induced IFN-γ production Nature 1997 386: 619–623
Gu Y et al. Activation of interferon-γ inducing factor mediated by interleukin-1β converting enzyme Science 1997 275: 206–209
Pecceu F et al. Human interleukin-1β fused to human growth hormone signal peptide is N-glycosylated and secreted by Chinese hamster ovary cells Gene 1991 97: 253–258
Wingren AG et al. Fusion of a signal sequence to the interleukin-1β gene directs the protein from cytoplasmic accumulation to extracellular release Cell Immunol 1996 169: 226–237
Ghivizzani SC et al. Constitutive intra-articular expression of human IL-1β following gene transfer to rabbit synovium produces all major pathologies of human rheumatoid arthritis J Immunol 1997 159: 3604–3612
Cerretti DP et al. Molecular cloning of the interleukin 1β converting enzyme Science 1992 256: 97–100
Thornberry NA et al. A novel heterodimetric cysteine protease is required for interleukin 1β processing in monocytes Nature 1992 356: 768–774
Young PR, Hazuda DJ, Simon PL . Human interleukin 1β is not secreted from hamster fibroblasts when expressed constitutively from a transfected cDNA J Cell Biol 1988 107: 447–456
Chen L et al. Eradication of murine bladder carcinoma by intra-tumor injection of a bicistronic adenoviral vector carrying cDNAs for the IL-12 heterodimer and its inhibition by the IL-12 p40 subunit homodimer J Immunol 1997 159: 351–359
Tahara H et al. Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector J Immunol 1995 154: 6466–6474
Brunda MJ et al. Antitumor and antimetastatic activity of interleukin 12 against murine tumors J Exp Med 1993 178: 1223–1230
Dao T et al. Interferon-gamma-inducing factor, a novel cytokine, enhances Fas ligand-mediated cytotoxicity of murine T helper 1 cells Cell Immunol 1996 173: 230–235
Tsutsui H et al. IFN-γ-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones J Immunol 1996 157: 3967–3973
Zitvogel L et al. Construction and characterization of retroviral vectors expressing biologically active human interleukin-12 Hum Gene Ther 1994 5: 1493–1506
Dranoff G et al. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte–macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity Proc Natl Acad Sci USA 1993 90: 3539–3543
Pear WS, Nolan ML, Scott ML, Baltimore D . Production of high-titer helper-free retroviruses by transient transfection Proc Natl Acad Sci USA 1993 90: 8392–8396
Hardy S et al. Construction of adenovirus vectors through cre-lox recombination J Virol 1997 71: 1842–1849
Okamura H et al. A novel costimulatory factor for gamma interferon induction found in the livers of mice causes endotoxic shock Infect Immun 1995 63: 3966–3972
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Osaki, T., Hashimoto, W., Gambotto, A. et al. Potent antitumor effects mediated by local expression of the mature form of the interferon-γ inducing factor, interleukin-18 (IL-18). Gene Ther 6, 808–815 (1999). https://doi.org/10.1038/sj.gt.3300908
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3300908
Keywords
This article is cited by
-
Role of the NLRP3 inflammasome in cancer
Molecular Cancer (2018)
-
SERS-based Immunoassay in a Microfluidic System for the Multiplexed Recognition of Interleukins from Blood Plasma: Towards Picogram Detection
Scientific Reports (2017)
-
Interleukin 12: still a promising candidate for tumor immunotherapy?
Cancer Immunology, Immunotherapy (2014)
-
Oncolytic adenovirus expressing interleukin-18 induces significant antitumor effects against melanoma in mice through inhibition of angiogenesis
Cancer Gene Therapy (2010)
-
A Functional SNP of the Interleukin-18 Gene Is Associated with the Presence of Hepatocellular Carcinoma in Hepatitis B Virus-Infected Patients
Digestive Diseases and Sciences (2009)